One billion dollars in annual sales.
It’s a milestone for a public company that signifies it’s a winner.
Customers will pay anything to use their products and services.
The competition shakes in its boots, realizing it has fallen behind and may never catch up.
Right now, seeing what’s going on in the market can make your head spin, but don’t’ worry, because it’s nothing that Strategic Tech Investor can’t handle.
Whenever I can, I like to point out just how important it is to avoid getting swept up in the big media hype that can push the market back and forth on temporary headlines. In fact, it’s my second rule of tech investing, “separate the signal from the noise.”
And wow, is that rule ever coming in handy right now, because we’re seeing headlines coming out now that could push the market any which way.
Let’s start with some good news. So far, three companies, Pfizer Inc. (PFE), Moderna Inc. (MRNA), and AstraZeneca PLC (AZN), have all announced this month that their COVID-19 vaccine candidates are demonstrating 90% efficacy rates in testing. However, it’s still unclear how long it will be until an effective vaccine is widely publicly available.
Not only that, but we are currently in a period of limbo between the Trump and Biden administrations, and the question of a new stimulus package isn’t settled.
We’re also seeing that state-level officials, like Governors Larry Hogan of Maryland and Kim Reynolds of Iowa, have announced new restrictions, with the possibility of more on the way.
With so much news, positive and negative, flooding onto the airwaves, it’s impossible to say for sure what will happen next. Luckily for us, it’s not going to matter.